AI Q&A With Pleio’s Michael Oleksiw

June 11, 2025

“OLLIE gives pharmaceutical companies a more honest view of the emotional and behavioral realities that shape adherence, grounded not in assumptions but in patients’ own words.” – Michael Oleksiw, Chief Executive Officer at Pleio